Related Experiment Videos
To save a child's spleen: 50 years from Toronto to ATOMAC
1Division of Pediatric Surgery, Columbia University Vagelos College of Physicians & Surgeons, Morgan Stanley Children's Hospital, 3959 Broadway - Rm 204 N, New York, NY 10032.
Insights
Pediatric surgeons pioneered non-operative spleen injury treatment for children over 50 years ago. This approach, initially controversial, now ensures safe outcomes with fewer surgeries and shorter hospital stays.
Area of Science:
- Pediatric Surgery
- Trauma Management
- Spleen Injury
Background:
- Non-operative management (NOM) for blunt spleen injury (BSI) in children was introduced over 50 years ago.
- NOM faced significant initial resistance from the adult surgical community.
Observation:
- Despite early skepticism, pediatric surgeons progressively refined NOM protocols for pediatric BSI.
- Current NOM pathways are characterized by high success rates.
Findings:
- Successful NOM in pediatric BSI is evidenced by infrequent splenectomies.
- Minimal blood transfusions are required in successfully managed cases.
- Patients managed non-operatively experience shorter hospital stays.
Implications:
- The historical evolution highlights a paradigm shift in pediatric trauma care.
- Contemporary clinical pathways for pediatric BSI are safe and efficient.
- This review examines the spleen's role and the development of modern treatment strategies.
Abstract:
Pediatric surgeons brought forth non-operative treatment for children with blunt spleen injury more than 50 years ago. At the time, this proposal was deemed reckless by many adult surgeons, and debate ensued for decades. Despite criticisms, pediatric surgeons refined the clinical pathways for children with spleen injury leading to current safe and efficient outcomes. These outcomes are defined by rare splenectomies, few blood transfusions, and short length of hospital stay. This review will address the role of the spleen through historical perceptions and scientific evidence. In addition, evolution of contemporary clinical pathways will be outlined.